Toni Vidal-Puig TVP Lab

Toni Vidal-Puig TVP Lab

Give online
to Toni Vidal-Puig TVP Lab

  • Syringe with vial

Obesity rates are continuing to rise worldwide and it is inevitable that associated illnesses, such as liver disease and diabetes will follow the same trend unless new therapeutic approaches are developed.

Our programme of research explores the molecular mechanisms involved in controlling energy expenditure and fat deposition. Every day we move closer to understanding the complex processes driving human disease and closer to developing new treatments.

Find out more

Toni Vidal-Puig TVP Lab website

Gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

A laboratory scientist
Gift announcement
Established as a charity in 1920, the Evelyn Trust makes grants to support medical research and health and wellbeing projects in Cambridgeshire. The Trust is particularly interested in research projects that have the potential to deliver transformational change, such as demonstration or pilot projects.
Gift announcement
The Vice-Chancellor celebrated the power of collegiate Cambridge and the importance of philanthropy in his annual address.

Related impact stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Fatty deposits on the liver
Philanthropic impact story
Dr Jules Griffin’s research seeks to understand and combat factors that contribute to obesity and fatty liver disease.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
Philanthropic impact story
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.